Author:
Gil-Nagel Antonio,Burd Sergey,Toledo Manuel,Sander Josemir W.,Lebedeva Anna,Patten Anna,Laurenza Antonio
Subject
Clinical Neurology,Neurology,General Medicine
Reference12 articles.
1. European Medicines Agency (EMA). Fycompa® Annex I: Summary of Product Characteristics, April 2017. Available at: http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/002434/WC500130815.pdf.
2. Food and Drug Administration (FDA). Fycompa® Prescribing Information, July 2017. Available at: https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/202834s012,208277s001lbl.pdf.
3. Adjunctive perampanel for refractory partial-onset seizures: randomized phase III study 304;French;Neurology,2012
4. Evaluation of adjunctive perampanel in patients with refractory partial-onset seizures: results of randomized global phase III study 305;French;Epilepsia,2013
5. Perampanel for tonic-clonic seizures in idiopathic generalized epilepsy: a randomized trial;French;Neurology,2015
Cited by
57 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献